Safe Use of DuoNeb in Patients with Angioedema

Introduction to Angioedema and DuoNeb

• The American Heart Association suggests that ACE inhibitors cause angioedema in less than 1% of patients through bradykinin pathway inhibition, occurring more frequently in Black patients and women 2, 3.
• The American College of Cardiology recommends that ACE inhibitor-induced angioedema is an absolute contraindication to all ACE inhibitors for life 2, 3.

Medication Safety and Angioedema Risk

• DuoNeb is completely safe in patients with ACE inhibitor-induced angioedema, as beta-agonists and anticholinergics do not affect bradykinin metabolism 1.
• The American College of Cardiology notes that ARBs have a much lower incidence of angioedema compared to ACE inhibitors 1.
• Neprilysin inhibitors combined with ACE inhibitors have high angioedema risk due to dual inhibition of bradykinin breakdown 5, 4.

Clinical Guidelines for DuoNeb Use

• The American Heart Association recommends that DuoNeb remains safe as it does not interact with the renin-angiotensin system 4.
• The American College of Cardiology suggests that beta-blockers remain Class I, Level A recommendations for heart failure with reduced ejection fraction and are not contraindicated in angioedema 1.

Contraindicated Medications

• The American Heart Association recommends avoiding all ACE inhibitors (absolute contraindication) in patients with prior angioedema 2, 7, 3, 8, 6.
• The American College of Cardiology notes that ARNIs are contraindicated in patients with a history of angioedema 5, 4.